May 15, 2025 From Awareness to Action: How C-Path’s HD-RSC Is Transforming the Future of Huntington’s Disease May 15, marks Huntington’s Disease Awareness Day, a key moment during Huntington’s Awareness...
May 12, 2025 C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today an $815,000 ($1,250,000 AUD) grant to Brian Dymock.
May 8, 2025 Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration The year 2025 marks a historic milestone for C-Path as the organization celebrates...
May 6, 2025 C-Path Announces First Data Transfer from Takeda to Accelerate Alpha-1 Innovation TUCSON, Ariz., May 6, 2025 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 (CPA-1) consortium is proud to ann
September 9, 2025-September 11, 2025 Registration is Now Open for the 2025 C-Path Global Impact Conference We’re excited to announce that registration is now open for the 2025 C-Path Global Impact Conference...
May 22, 2025 RDCA-DAP and NORD’s IAMRARE Platform to Platform Federation: Lessons Learned Patient data is a key asset in understanding the progression of rare diseases...
April 28, 2025 Lysosomal Storage Disease Data Sharing Webinar Series – Session #3: Retroactive Data Sharing The recent webinar from C-Path’s Critical Path for Lysosomal Diseases (CPLD) team focused on the critical issue of retroacti
April 25, 2025 Developing digital health technologies for frontotemporal degeneration Frontotemporal degeneration (FTD) is a rare neurodegenerative disease in which patients can present with cognitive, behavioral...
April 25, 2025 C-Path’s CPAD Database Drives Insights into Alzheimer’s Disease C-Path’s Critical Path for Alzheimer’s Disease (CPAD) Consortium is thrilled to share...
April 25, 2025 C-Path’s Stephenson Featured in BioCentury Article C-Path Vice President of Neurology and Executive Director of Critical Path for Parkinson's (CPP) Consortium...